SOX9 and melanoma: Inactivating the neural crest transcription factor sox10 in these tumors significantly decreased melanoma initiation but resulted in rare invasive tumors that highly expressed the sox9 transcription factor, highlighting that unexpected in vivo phenotypes can emerge that aren’t predicted from in vitro studies (Capparelli et al., 2022; Wouters et al., 2020).